Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Post-Treatment Platelet Reactivity”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT00915733
What this trial is testing

Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism

Who this might be right for
Myocardial Infarction
Gyeongsang National University Hospital 80
Not applicableStudy completedNCT01744613
What this trial is testing

High on Treatment Platelet Reactivity Following Peripheral Endovascular Procedures

Who this might be right for
Influence of PRU Values on Primary Outcome
University of Patras 100
Large-scale testing (Phase 3)UnknownNCT00891670
What this trial is testing

Comparison of Platelet Inhibition With Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel According to Hepatic Cytochrome 2C19 Allele (CYP2C19) Polymorphism

Who this might be right for
Coronary Artery StenosisMaximal Platelet AggregationLate Platelet Aggregation+1 more
Gyeongsang National University Hospital 80
Not applicableLooking for participantsNCT05936606
What this trial is testing

Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients

Who this might be right for
Coronary Artery Disease
Yonsei University 3,434
Post-approval studies (Phase 4)Study completedNCT01371058
What this trial is testing

Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)

Who this might be right for
Coronary Artery Disease
Shenyang Northern Hospital 350
Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Post-approval studies (Phase 4)Study completedNCT01955200
What this trial is testing

OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial

Who this might be right for
Coronary Artery Disease
The First Affiliated Hospital with Nanjing Medical University 1,724
Post-approval studies (Phase 4)Study completedNCT02096419
What this trial is testing

Continuous Clopidogrel Dose Adjustment in Acute Coronary Syndrome Patients With High On-treatment Platelet Reactivity

Who this might be right for
Acute Coronary Syndrome
University of Zagreb 87
Post-approval studies (Phase 4)Study completedNCT01493999
What this trial is testing

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity

Who this might be right for
Acute Coronary Syndrome
University of Pecs 147
Not applicableStudy completedNCT02101411
What this trial is testing

Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)

Who this might be right for
PRU(Platelet Reactivity Unit)APT(Antiplatelet Therapy)HOTPR(High on Treat Platelet Reactivity)
Taipei City Hospital 334
Post-approval studies (Phase 4)Study completedNCT04927949
What this trial is testing

Evaluation of Myocardial Reperfusion After Primary PCI in Patients With High Platelet Reactivity Treated by Cangrelor or Not

Who this might be right for
ST-elevation Myocardial Infarction
University Hospital, Caen 128
Large-scale testing (Phase 3)Looking for participantsNCT07582835
What this trial is testing

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino 355